Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Eric Ahlskog

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Concepts & Ideas

Procedures

Case-Control Studies

Anatomy

Physiology

Disease Progression

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Savica R; Grossardt B R; Carlin J M; Icen M; Bower J H; Ahlskog J E; Maraganore D M; Steensma D P; Rocca W A
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.
Frigerio Roberta; Fujishiro Hiroshige; Maraganore Demetrius M; Klos Kevin J; DelleDonne Anthony; Heckman Michael G; Crook Julia E; Josephs Keith A; Parisi Joseph E; Boeve Bradley F; Dickson Dennis W; Ahlskog J Eric
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
Orr Carolyn F; Ahlskog J Eric
Frequency, characteristics, and risk factors for amiodarone neurotoxicity.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Eric Ahlskog (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Savica R; Grossardt B R; Carlin J M; Icen M; Bower J H; Ahlskog J E; Maraganore D M; Steensma D P; Rocca W A
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.
Neurology 2009;73(17):1381-7.
2009: Frigerio Roberta; Fujishiro Hiroshige; Maraganore Demetrius M; Klos Kevin J; DelleDonne Anthony; Heckman Michael G; Crook Julia E; Josephs Keith A; Parisi Joseph E; Boeve Bradley F; Dickson Dennis W; Ahlskog J Eric
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
Archives of neurology 2009;66(9):1114-9.
2009: Orr Carolyn F; Ahlskog J Eric
Frequency, characteristics, and risk factors for amiodarone neurotoxicity.
Archives of neurology 2009;66(7):865-9.
2009: Lipp Axel; Sandroni Paola; Ahlskog J Eric; Fealey Robert D; Kimpinski Kurt; Iodice Valeria; Gehrking Tonette L; Weigand Stephen D; Sletten David M; Gehrking Jade A; Nickander Kim K; Singer Wolfgang; Maraganore Demetrius M; Gilman Sid; Wenning Gregor K; Shults Clifford W; Low Phillip A
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
Archives of neurology 2009;66(6):742-50.
2009: Bostwick J Michael; Hecksel Kathleen A; Stevens Susanna R; Bower James H; Ahlskog J Eric
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
Mayo Clinic proceedings. Mayo Clinic 2009;84(4):310-6.
2009: McKeon Andrew; Ahlskog J Eric; Britton Jeffrey A; Lennon Vanda A; Pittock Sean J
Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images.
Archives of neurology 2009;66(2):268-71.
2009: Josephs Keith A; Ahlskog J Eric; Parisi Joseph E; Boeve Bradley F; Crum Brian A; Giannini Caterina; Petersen Ronald C
Rapidly progressive neurodegenerative dementias.
Archives of neurology 2009;66(2):201-7.
2009: McKeon Andrew; Ahlskog J Eric; Bower James H; Josephs Keith A; Matsumoto Joseph Y
Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(1):72-6.
2008: McKeon Andrew; Matsumoto Joseph Y; Bower James H; Ahlskog J Eric
The spectrum of disorders presenting as adult-onset focal lower extremity dystonia.
Parkinsonism & related disorders 2008;14(8):613-9.
2008: Orzechowski Nicole M; Wolanskyj Alexandra P; Ahlskog J Eric; Kumar Neeraj; Moder Kevin G
Antiphospholipid antibody-associated chorea.
The Journal of rheumatology 2008;35(11):2165-70.
2008: Kumar Neeraj; Krueger Bruce R; Ahlskog J Eric
Hemimasticatory spasm with lateral jaw deviations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2265-6.
2008: DelleDonne Anthony; Klos Kevin J; Fujishiro Hiroshige; Ahmed Zeshan; Parisi Joseph E; Josephs Keith A; Frigerio Roberta; Burnett Melinda; Wszolek Zbigniew K; Uitti Ryan J; Ahlskog J Eric; Dickson Dennis W
Incidental Lewy body disease and preclinical Parkinson disease.
Archives of neurology 2008;65(8):1074-80.
2008: Fujishiro Hiroshige; Frigerio Roberta; Burnett Melinda; Klos Kevin J; Josephs Keith A; Delledonne Anthony; Parisi Joseph E; Ahlskog J Eric; Dickson Dennis W
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(8):1085-92.
2008: McKeon Andrew; Ahlskog J Eric; Matsumoto Joseph Y
Psychogenic tremor occurring after deep brain stimulation surgery for essential tremor.
Neurology 2008;70(16 Pt 2):1498-9.
2008: Dickson Dennis W; Fujishiro Hiroshige; DelleDonne Anthony; Menke Joshua; Ahmed Zeshan; Klos Kevin J; Josephs Keith A; Frigerio Roberta; Burnett Melinda; Parisi Joseph E; Ahlskog J Eric
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Acta neuropathologica 2008;115(4):437-44.
2008: Rocca W A; Bower J H; Maraganore D M; Ahlskog J E; Grossardt B R; de Andrade M; Melton L J
Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
Neurology 2008;70(3):200-9.
2008: Lesnick Timothy G; Sorenson Eric J; Ahlskog J Eric; Henley John R; Shehadeh Lina; Papapetropoulos Spiridon; Maraganore Demetrius M
Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway.
PloS one 2008;3(1):e1449.
2007: Arabia Gennarina; Grossardt Brandon R; Geda Yonas E; Carlin Justin M; Bower James H; Ahlskog J Eric; Maraganore Demetrius M; Rocca Walter A
Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease.
Archives of general psychiatry 2007;64(12):1385-92.
2007: Boeve B F; Silber M H; Saper C B; Ferman T J; Dickson D W; Parisi J E; Benarroch E E; Ahlskog J E; Smith G E; Caselli R C; Tippman-Peikert M; Olson E J; Lin S-C; Young T; Wszolek Z; Schenck C H; Mahowald M W; Castillo P R; Del Tredici K; Braak H
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.
Brain : a journal of neurology 2007;130(Pt 11):2770-88.
2007: Hu William T; Parisi Joseph E; Knopman David S; Boeve Bradley F; Dickson Dennis W; Ahlskog J Eric; Petersen Ronald C; Josephs Keith A
Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia.
Alzheimer disease and associated disorders 2007;21(4):S39-43.
2007: Ahlskog J Eric
Beating a dead horse: dopamine and Parkinson disease.
Neurology 2007;69(17):1701-11.
2007: Rocca Walter A; Bower James H; Ahlskog J Eric; Elbaz Alexis; Grossardt Brandon R; McDonnell Shannon K; Schaid Daniel J; Maraganore Demetrius M
Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.
Archives of neurology 2007;64(10):1458-64.
2007: Ahlskog J Eric
I can't get no satisfaction: still no neuroprotection for Parkinson disease.
Neurology 2007;69(15):1476-7.
2007: McKeon Andrew; Pittock Sean J; Glass Graham A; Josephs Keith A; Bower James H; Lennon Vanda A; Ahlskog J Eric
Whole-body tremulousness: isolated generalized polymyoclonus.
Archives of neurology 2007;64(9):1318-22.
2007: Rocca W A; Bower J H; Maraganore D M; Ahlskog J E; Grossardt B R; de Andrade M; Melton L J
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
Neurology 2007;69(11):1074-83.
2007: Kumar N; McKeon A; Rabinstein A A; Kalina P; Ahlskog J E; Mokri B
Superficial siderosis and csf hypovolemia: the defect (dural) in the link.
Neurology 2007;69(9):925-6.
2007: Rocca Walter A; Bower James H; Ahlskog J Eric; Elbaz Alexis; Grossardt Brandon R; McDonnell Shannon K; Schaid Daniel J; Maraganore Demetrius M
Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(11):1607-14.
2007: Lipp A; Sandroni P; Ahlskog J Eric; Maraganore D M; Shults C W; Low P A
Calf venous compliance in multiple system atrophy.
American journal of physiology. Heart and circulatory physiology 2007;293(1):H260-5.
2007: Lesnick Timothy G; Papapetropoulos Spiridon; Mash Deborah C; Ffrench-Mullen Jarlath; Shehadeh Lina; de Andrade Mariza; Henley John R; Rocca Walter A; Ahlskog J Eric; Maraganore Demetrius M
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.
PLoS genetics 2007;3(6):e98.
2007: Glass Graham A; Ahlskog J Eric; Matsumoto Joseph Y
Orthostatic myoclonus: a contributor to gait decline in selected elderly.
Neurology 2007;68(21):1826-30.
2007: Frigerio Roberta; Breteler Monique M B; de Lau Lonneke M L; Sanft Kevin R; Bower James H; Ahlskog J Eric; Grossardt Brandon R; Maraganore Demetrius M; Rocca Walter A
Number of children and risk of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(5):632-9.
2007: Boeve B F; Dickson D W; Olson E J; Shepard J W; Silber M H; Ferman T J; Ahlskog J E; Benarroch E E
Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease.
Sleep medicine 2007;8(1):60-4.
2006: Klos K J; Ahlskog J E; Kumar N; Cambern S; Butz J; Burritt M; Fealey R D; Cowl C T; Parisi J E; Josephs K A
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity.
Neurology 2006;67(11):1984-9.
2006: Mokri Bahram; Ahlskog J Eric; Luetmer Patrick H
Chorea as a manifestation of spontaneous CSF leak.
Neurology 2006;67(8):1490-1.
2006: Klos K J; Chandler M; Kumar N; Ahlskog J E; Josephs K A
Neuropsychological profiles of manganese neurotoxicity.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(10):1139-41.
2006: Krabbe J G; Gao F; Li J; Ahlskog J E; Lingeman H; Niessen W M A; Irth H
Selective detection and identification of phosphorylated proteins by simultaneous ligand-exchange fluorescence detection and mass spectrometry.
Journal of chromatography. A 2006;1130(2):287-95.
2006: Frigerio Roberta; Sanft Kevin R; Grossardt Brandon R; Peterson Brett J; Elbaz Alexis; Bower James H; Ahlskog J Eric; de Andrade Mariza; Maraganore Demetrius M; Rocca Walter A
Chemical exposures and Parkinson's disease: a population-based case-control study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1688-92.
2006: Pittock Sean J; Yoshikawa Hiroaki; Ahlskog J Eric; Tisch Stephen H; Benarroch Eduardo E; Kryzer Thomas J; Lennon Vanda A
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction.
Mayo Clinic proceedings. Mayo Clinic 2006;81(9):1207-14.
2006: Bower J H; Maraganore D M; Peterson B J; Ahlskog J E; Rocca W A
Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
Neurology 2006;67(3):494-6.
2006: Glass Graham A; Josephs Keith A; Ahlskog J Eric
Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy.
Archives of neurology 2006;63(7):978-81.
2006: Davidzon Guido; Greene Paul; Mancuso Michelangelo; Klos Kevin J; Ahlskog J Eric; Hirano Michio; DiMauro Salvatore
Early-onset familial parkinsonism due to POLG mutations.
Annals of neurology 2006;59(5):859-62.
2006: McDonnell Shannon K; Schaid Daniel J; Elbaz Alexis; Strain Kari J; Bower James H; Ahlskog J Eric; Maraganore Demetrius M; Rocca Walter A
Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study.
Annals of neurology 2006;59(5):788-95.
2006: Kumar N; Cohen-Gadol A A; Wright R A; Miller G M; Piepgras D G; Ahlskog J E
Superficial siderosis.
Neurology 2006;66(8):1144-52.
2006: Klos K J; Ahlskog J E; Josephs K A; Apaydin H; Parisi J E; Boeve B F; DeLucia M W; Dickson D W
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals.
Neurology 2006;66(7):1100-2.
2006: Josephs Keith A; Matsumoto Joseph Y; Ahlskog J Eric
Benign tremulous parkinsonism.
Archives of neurology 2006;63(3):354-7.
2006: Van Gerpen Jay A; Kumar Neeraj; Bower James H; Weigand Stephen; Ahlskog J Eric
Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
Archives of neurology 2006;63(2):205-9.
2006: Kumar Neeraj; Ahlskog J Eric; Klein Christopher J; Port John D
Imaging features of copper deficiency myelopathy: a study of 25 cases.
Neuroradiology 2006;48(2):78-83.
2006: Rocca Walter A; Grossardt Brandon R; Peterson Brett J; Bower James H; Trenerry Max R; Ahlskog J Eric; Sanft Kevin R; de Andrade Mariza; Maraganore Demetrius M
The Mayo Clinic cohort study of personality and aging: design and sampling, reliability and validity of instruments, and baseline description.
Neuroepidemiology 2006;26(3):119-29.
2005: Frigerio R; Elbaz A; Sanft K R; Peterson B J; Bower J H; Ahlskog J E; Grossardt B R; de Andrade M; Maraganore D M; Rocca W A
Education and occupations preceding Parkinson disease: a population-based case-control study.
Neurology 2005;65(10):1575-83.
2005: Klos Kevin J; Ahlskog J Eric; Josephs Keith A; Fealey Robert D; Cowl Clayton T; Kumar Neeraj
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity.
Archives of neurology 2005;62(9):1385-90.
2005: Klos Kevin J; Bower James H; Josephs Keith A; Matsumoto Joseph Y; Ahlskog J Eric
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Parkinsonism & related disorders 2005;11(6):381-6.
2005: Dodd M Leann; Klos Kevin J; Bower James H; Geda Yonas E; Josephs Keith A; Ahlskog J Eric
Pathological gambling caused by drugs used to treat Parkinson disease.
Archives of neurology 2005;62(9):1377-81.
2005: Kumar Neeraj; Elliott Michelle A; Hoyer James D; Harper Charles M; Ahlskog J Eric; Phyliky Robert L
"Myelodysplasia," myeloneuropathy, and copper deficiency.
Mayo Clinic proceedings. Mayo Clinic 2005;80(7):943-6.
2005: Hu William T; Josephs Keith A; Ahlskog J Eric; Shin Cheolsu; Boeve Bradley F; Witte Robert J
MRI correlates of alien leg-like phenomenon in corticobasal degeneration.
Movement disorders : official journal of the Movement Disorder Society 2005;20(7):870-3.
2005: Josephs K A; Ahlskog J E; Klos K J; Kumar N; Fealey R D; Trenerry M R; Cowl C T
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity.
Neurology 2005;64(12):2033-9.
2005: Facheris Maurizio; Strain Kari J; Lesnick Timothy G; de Andrade Mariza; Bower James H; Ahlskog J Eric; Cunningham Julie M; Lincoln Sarah; Farrer Mathew J; Rocca Walter A; Maraganore Demetrius M
UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study.
Neuroscience letters 2005;381(1-2):131-4.
2005: Elbaz Alexis; Peterson Brett J; Bower James H; Yang Ping; Maraganore Demetrius M; McDonnell Shannon K; Ahlskog J Eric; Rocca Walter A
Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):719-25.
2005: Mamah Catherine E; Lesnick Timothy G; Lincoln Sarah J; Strain Kari J; de Andrade Mariza; Bower James H; Ahlskog J Eric; Rocca Walter A; Farrer Matthew J; Maraganore Demetrius M
Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
Annals of neurology 2005;57(3):439-43.
2005: Kumar Neeraj; Van Gerpen Jay A; Bower James H; Ahlskog J Eric
Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
Movement disorders : official journal of the Movement Disorder Society 2005;20(3):342-4.
2005: Ahlskog J Eric
Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(3):271-82.
2005: Ravina B; Eidelberg D; Ahlskog J E; Albin R L; Brooks D J; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz R G; Kieburtz K; Kish S J; Lange N; Langston J W; Marek K; Morin L; Moy C; Murphy D; Oertel W H; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi K D; Shults C W; Sheehy P; Stoessl A J; Holloway R
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Rocca Walter A; Peterson Brett J; McDonnell Shannon K; Bower James H; Ahlskog J Eric; Schaid Daniel J; Maraganore Demetrius M
The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics.
Neuroepidemiology 2005;24(3):151-67.
2004: Kumar Neeraj; Ahlskog J Eric; Gross John B
Acquired hypocupremia after gastric surgery.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(12):1074-9.
2004: Rocca Walter A; McDonnell Shannon K; Strain Kari J; Bower James H; Ahlskog J Eric; Elbaz Alexis; Schaid Daniel J; Maraganore Demetrius M
Familial aggregation of Parkinson's disease: The Mayo Clinic family study.
Annals of neurology 2004;56(4):495-502.
2004: Maraganore D M; Wilkes K; Lesnick T G; Strain K J; de Andrade M; Rocca W A; Bower J H; Ahlskog J E; Lincoln S; Farrer M J
A limited role for DJ1 in Parkinson disease susceptibility.
Neurology 2004;63(3):550-3.
2004: Kumar Neeraj; Gross John B; Ahlskog J Eric
Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration.
Neurology 2004;63(1):33-9.
2004: Pittock Sean J; Parrett Timothy; Adler Charles H; Parisi Joseph E; Dickson Dennis W; Ahlskog J Eric
Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):695-9.
2004: Ahlskog J Eric
Trimethobenzamide in elderly patients.
Mayo Clinic proceedings. Mayo Clinic 2004;79(6):829.
2004: Kumar Neeraj; Crum Brian; Petersen Ronald C; Vernino Steven A; Ahlskog J Eric
Copper deficiency myelopathy.
Archives of neurology 2004;61(5):762-6.
2004: Kumar Neeraj; Ahlskog J Eric
Myelopolyneuropathy due to copper deficiency or zinc excess?
Archives of neurology 2004;61(4):604-5; author reply 605.
2004: Mokri Bahram; Ahlskog J Eric; Fulgham Jimmy R; Matsumoto Joseph Y
Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm.
Neurology 2004;62(6):971-3.
2003: Kumar Neeraj; McEvoy Kathleen M; Ahlskog J Eric
Myelopathy due to copper deficiency following gastrointestinal surgery.
Archives of neurology 2003;60(12):1782-5.
2003: Van Gerpen J A; Ahlskog J E; Petty G W
Progressive supranuclear palsy phenotype secondary to CADASIL.
Parkinsonism & related disorders 2003;9(6):367-9.
2003: Ahlskog J Eric
Parkinson's disease: is the initial treatment established?
Current neurology and neuroscience reports 2003;3(4):289-95.
2003: Kumar Neeraj; Gross John B; Ahlskog J Eric
Myelopathy due to copper deficiency.
Neurology 2003;61(2):273-4.
2003: Boeve B F; Silber M H; Parisi J E; Dickson D W; Ferman T J; Benarroch E E; Schmeichel A M; Smith G E; Petersen R C; Ahlskog J E; Matsumoto J Y; Knopman D S; Schenck C H; Mahowald M W
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.
Neurology 2003;61(1):40-5.
2003: Elbaz A; McDonnell S K; Maraganore D M; Strain K J; Schaid D J; Bower J H; Ahlskog J E; Rocca W A
Validity of family history data on PD: evidence for a family information bias.
Neurology 2003;61(1):11-7.
2003: Cohen-Gadol Aaron A; Ahlskog J Eric; Matsumoto Joseph Y; Swenson Mary A; McClelland Robyn L; Davis Dudley H
Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic.
Journal of neurosurgery 2003;98(6):1247-54.
2003: Bower J H; Maraganore D M; Peterson B J; McDonnell S K; Ahlskog J E; Rocca W A
Head trauma preceding PD: a case-control study.
Neurology 2003;60(10):1610-5.
2003: Ahlskog J Eric
Slowing Parkinson's disease progression: recent dopamine agonist trials.
Neurology 2003;60(3):381-9.
2003: Elbaz Alexis; Bower James H; Peterson Brett J; Maraganore Demetrius M; McDonnell Shannon K; Ahlskog J Eric; Schaid Daniel J; Rocca Walter A
Survival study of Parkinson disease in Olmsted County, Minnesota.
Archives of neurology 2003;60(1):91-6.
2002: Ahlskog J Eric; Maraganore Demetrius M; Uitti Ryan J; Uhl George R
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.
JAMA : the journal of the American Medical Association 2002;288(3):311; author reply 312-3.
2002: Elbaz Alexis; Peterson Brett J; Yang Ping; Van Gerpen Jay A; Bower James H; Maraganore Demetrius M; McDonnell Shannon K; Ahlskog J Eric; Rocca Walter A
Nonfatal cancer preceding Parkinson's disease: a case-control study.
Epidemiology (Cambridge, Mass.) 2002;13(2):157-64.
2002: Apaydin Hulya; Ahlskog J Eric; Parisi Joseph E; Boeve Bradley F; Dickson Dennis W
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
Archives of neurology 2002;59(1):102-12.
2002: Elbaz Alexis; Bower James H; Maraganore Demetrius M; McDonnell Shannon K; Peterson Brett J; Ahlskog J Eric; Schaid Daniel J; Rocca Walter A
Risk tables for parkinsonism and Parkinson's disease.
Journal of clinical epidemiology 2002;55(1):25-31.
2001: Matsumoto J; Morrow D; Kaufman K; Davis D; Ahlskog J E; Walker A; Sneve D; Noseworthy J; Rodriguez M
Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures.
Neurology 2001;57(10):1876-82.
2001: Tsuboi Y; Ahlskog J E; Apaydin H; Parisi J E; Dickson D W
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.
Neurology 2001;57(9):1675-8.
2001: Ahlskog J E; Nishino H; Evidente V G; Tulloch J W; Forbes G S; Caviness J N; Gwinn-Hardy K A
Persistent chorea triggered by hyperglycemic crisis in diabetics.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):890-8.
2001: Benedetti M D; Maraganore D M; Bower J H; McDonnell S K; Peterson B J; Ahlskog J E; Schaid D J; Rocca W A
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):830-7.
2001: Ahlskog J E
Parkinson's disease: medical and surgical treatment.
Neurologic clinics 2001;19(3):579-605, vi.
2001: Van Gerpen J A; Ahlskog J E
Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
Neurology 2001;57(2):368-9; author reply 369-70.
2001: Ahlskog J E; Muenter M D
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):448-58.
2000: Benedetti M D; Bower J H; Maraganore D M; McDonnell S K; Peterson B J; Ahlskog J E; Schaid D J; Rocca W A
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.
Neurology 2000;55(9):1350-8.
2000: Van Gerpen J A; Matsumoto J Y; Ahlskog J E; Maraganore D M; McManis P G
Utility of an EMG mapping study in treating cervical dystonia.
Muscle & nerve 2000;23(11):1752-6.
2000: Wright R A; Ahlskog J E
Focal shoulder-elevation dystonia.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):709-13.
2000: Shiba M; Bower J H; Maraganore D M; McDonnell S K; Peterson B J; Ahlskog J E; Schaid D J; Rocca W A
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):669-77.
2000: Beran-Koehn M A; Zupanc M L; Patterson M C; Olk D G; Ahlskog J E
Violent recurrent ballism associated with infections in two children with static encephalopathy.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):570-4.
2000: Hurt R D; Ahlskog J E; Croghan G A; Offord K P; Wolter T D; Croghan I T; Moyer T P
Carbidopa/levodopa for smoking cessation: a pilot study with negative results.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2000;2(1):71-8.
1999: Ahlskog J E
Medical treatment of later-stage motor problems of Parkinson disease.
Mayo Clinic proceedings. Mayo Clinic 1999;74(12):1239-54.
1999: Ahlskog J E; Uitti R J; O'Connor M K; Maraganore D M; Matsumoto J Y; Stark K F; Turk M F; Burnett O L
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):940-6.
1999: Boeve B F; Maraganore D M; Parisi J E; Ahlskog J E; Graff-Radford N; Caselli R J; Dickson D W; Kokmen E; Petersen R C
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.
Neurology 1999;53(4):795-800.
1999: Pérez-Tur J; Buée L; Morris H R; Waring S C; Onstead L; Wavrant-De Vrièze F; Crook R; Buée-Scherrer V; Hof P R; Petersen R C; McGeer P L; Delacourte A; Hutton M; Siddique T; Ahlskog J E; Hardy J; Steele J C
Neurodegenerative diseases of Guam: analysis of TAU.
Neurology 1999;53(2):411-3.
1999: Ahlskog J E; Litchy W J; Peterson R C; Waring S C; Esteban-Santillan C; Chen K M; Harper C M; Craig U K; Kurland L T
Guamanian neurodegenerative disease: electrophysiologic findings.
Journal of the neurological sciences 1999;166(1):28-35.
1999: Ling L H; Ahlskog J E; Munger T M; Limper A H; Oh J K
Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1999;74(4):371-5.
1998: Ahlskog J E; Waring S C; Petersen R C; Esteban-Santillan C; Craig U K; O'Brien P C; Plevak M F; Kurland L T
Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia.
Neurology 1998;51(6):1672-7.
1998: Dewey R B; Maraganore D M; Ahlskog J E; Matsumoto J Y
A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13(5):782-7.
1998: Chabolla D R; Maraganore D M; Ahlskog J E; O'Brien P C; Rocca W A
Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota.
Mayo Clinic proceedings. Mayo Clinic 1998;73(8):724-7.
1998: Kompoliti K; Goetz C G; Boeve B F; Maraganore D M; Ahlskog J E; Marsden C D; Bhatia K P; Greene P E; Przedborski S; Seal E C; Burns R S; Hauser R A; Gauger L L; Factor S A; Molho E S; Riley D E
Clinical presentation and pharmacological therapy in corticobasal degeneration.
Archives of neurology 1998;55(7):957-61.
1998: Moellentine C; Rummans T; Ahlskog J E; Harmsen W S; Suman V J; O'Connor M K; Black J L; Pileggi T
Effectiveness of ECT in patients with parkinsonism.
The Journal of neuropsychiatry and clinical neurosciences 1998;10(2):187-93.
1997: Low P A; Ahlskog J E; Petersen R C; Waring S C; Esteban-Santillan C; Kurland L T
Autonomic failure in Guamanian neurodegenerative disease.
Neurology 1997;49(4):1031-4.
1997: Ahlskog J E; Petersen R C; Waring S C; Esteban-Santillan C; Craig U K; Maraganore D M; Lennon V A; Kurland L T
Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?
Neurology 1997;48(5):1356-62.
1997: Kumar R; Maraganore D M; Ahlskog J E; Rodriguez M
Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone.
Neurology 1997;48(3):732-5.
1997: Koch L D; Cofield R H; Ahlskog J E
Total shoulder arthroplasty in patients with Parkinson's disease.
Journal of shoulder and elbow surgery / American Shoulder and Elbow Surgeons ... [et al.] 1997;6(1):24-8.
1996: Ahlskog J E
Treatment of early Parkinson's disease: are complicated strategies justified?
Mayo Clinic proceedings. Mayo Clinic 1996;71(7):659-70.
1996: Ahlskog J E; Wright K F; Muenter M D; Adler C H
Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect.
Clinical neuropharmacology 1996;19(3):202-12.
1996: Dewey R B; Maraganore D M; Ahlskog J E; Matsumoto J Y
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
Clinical neuropharmacology 1996;19(3):193-201.
1996: Uitti R J; Rajput A H; Ahlskog J E; Offord K P; Schroeder D R; Ho M M; Prasad M; Rajput A; Basran P
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.
Neurology 1996;46(6):1551-6.
1996: Uitti R J; Ahlskog J E; Maraganore D M
Does levodopa therapy delay death in Parkinson's disease?
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):343-4.
1996: Hutton J T; Koller W C; Ahlskog J E; Pahwa R; Hurtig H I; Stern M B; Hiner B C; Lieberman A; Pfeiffer R F; Rodnitzky R L; Waters C H; Muenter M D; Adler C H; Morris J L
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.
Neurology 1996;46(4):1062-5.
1996: Ahlskog J E; Uitti R J; Tyce G M; O'Brien J F; Petersen R C; Kokmen E
Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.
Journal of the neurological sciences 1996;136(1-2):162-8.
1996: Ahlskog J E; Uitti R J; Low P A; Tyce G M; O'Brien J F; Nickander K K
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
Neurology 1996;46(3):796-801.
1995: Ahlskog J E; Uitti R J; Low P A; Tyce G M; Nickander K K; Petersen R C; Kokmen E
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):566-73.
1995: Ahlskog J E; Waring S C; Kurland L T; Petersen R C; Moyer T P; Harmsen W S; Maraganore D M; O'Brien P C; Esteban-Santillan C; Bush V
Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.
Neurology 1995;45(7):1340-4.
1995: Britton J W; Uitti R J; Ahlskog J E; Robinson R G; Kremer B; Hayden M R
Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.
Neurology 1995;45(3 Pt 1):443-7.
1995: Collins S J; Ahlskog J E; Parisi J E; Maraganore D M
Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.
Journal of neurology, neurosurgery, and psychiatry 1995;58(2):167-73.
1995: Ahlskog J E
Diagnostic steps for suspected Parkinson's disease.
Contemporary internal medicine 1995;7(1):22-30.
1994: Ahlskog J E; Muenter M D; Maraganore D M; Matsumoto J Y; Lieberman A; Wright K F; Wheeler K
Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.
Archives of neurology 1994;51(12):1236-41.
1994: Goetz C G; Stebbins G T; Shale H M; Lang A E; Chernik D A; Chmura T A; Ahlskog J E; Dorflinger E E
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):390-4.
1994: Ahlskog J E
Treatment of Parkinson's disease. From theory to practice.
Postgraduate medicine 1994;95(5):52-4, 57-8, 61-4 passim.
1994: Radhakrishnan K; Ahlskog J E; Garrity J A; Kurland L T
Idiopathic intracranial hypertension.
Mayo Clinic proceedings. Mayo Clinic 1994;69(2):169-80.
1993: Uitti R J; Ahlskog J E; Maraganore D M; Muenter M D; Atkinson E J; Cha R H; O'Brien P C
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.
Neurology 1993;43(10):1918-26.
1993: Lieberman A; Imke S; Muenter M; Wheeler K; Ahlskog J E; Matsumoto J Y; Maraganore D M; Wright K F; Schoenfelder J
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.
Neurology 1993;43(10):1981-4.
1993: Ahlskog J E
Cerebral transplantation for Parkinson's disease: current progress and future prospects.
Mayo Clinic proceedings. Mayo Clinic 1993;68(6):578-91.
1993: Goldman S; Ahlskog J E
Posttraumatic cervical dystonia.
Mayo Clinic proceedings. Mayo Clinic 1993;68(5):443-8.
1993: Radhakrishnan K; Ahlskog J E; Cross S A; Kurland L T; O'Fallon W M
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990.
Archives of neurology 1993;50(1):78-80.
1992: Auger R G; Litchy W J; Cascino T L; Ahlskog J E
Hemimasticatory spasm: clinical and electrophysiologic observations.
Neurology 1992;42(12):2263-6.
1992: Goldman M S; Ahlskog J E; Kelly P J
The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor.
Journal of neurosurgery 1992;76(6):924-8.
1992: Ahlskog J E; Muenter M D; Bailey P A; Stevens P M
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)
Archives of neurology 1992;49(5):560-8.
1992: Oh J J; Rummans T A; O'Connor M K; Ahlskog J E
Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness.
The American journal of psychiatry 1992;149(2):271.
1992: Maraganore D M; Folger W N; Swanson J W; Ahlskog J E
Movement disorders as sequelae of central pontine myelinolysis: report of three cases.
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):142-8.
1991: Fox M W; Ahlskog J E; Kelly P J
Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.
Journal of neurosurgery 1991;75(5):723-30.
1991: Stoddard S L; Tyce G M; Ahlskog J E; Zinsmeister A R; Nelson D K; Carmichael S W
Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla.
Experimental neurology 1991;114(1):23-7.
1991: Koller W C; Block G A; Ahlskog J E; Ahrens S; Cedarbaum J M; Cyhan G; Goetz C G; LeWitt P A; Liss C; McLean L
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
Clinical neuropharmacology 1991;14(4):322-9.
1991: Ahlskog J E; Richelson E; Nelson A; Kelly P J; Okazaki H; Tyce G M; van Heerden J A; Stoddard S L; Carmichael S W
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
Annals of neurology 1991;30(2):185-91.
1991: Sandroni P; Ahlskog J E; Fealey R D; Low P A
Autonomic involvement in extrapyramidal and cerebellar disorders.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1991;1(2):147-55.
1991: Ahlskog J E; Muenter M D; Bailey P A; Miller P M
Parkinson's disease monotherapy with controlled-release MK-458 (PHNO): double-blind study and comparison to carbidopa/levodopa.
Clinical neuropharmacology 1991;14(3):214-27.
1991: Davis D H; Ahlskog J E; Litchy W J; Root L M
Selective peripheral denervation for torticollis: preliminary results.
Mayo Clinic proceedings. Mayo Clinic 1991;66(4):365-71.
1990: Ahlskog J E
Parkinson's disease: new treatment strategies.
Comprehensive therapy 1990;16(12):41-6.
1990: Ahlskog J E; Kelly P J; van Heerden J A; Stoddard S L; Tyce G M; Windebank A J; Bailey P A; Bell G N; Blexrud M D; Carmichael S W
Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies.
Mayo Clinic proceedings. Mayo Clinic 1990;65(3):305-28.
1990: Yaksh T L; Carmichael S W; Stoddard S L; Tyce G M; Kelly P J; Lucas D; van Heerden J A; Ahlskog J E; Byer D E
Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus.
The Journal of laboratory and clinical medicine 1990;115(3):346-51.
1990: Ahlskog J E; Wilkinson J M
New concepts in the treatment of Parkinson's disease.
American family physician 1990;41(2):574-84.
1989: Tyce G M; Ahlskog J E; Carmichael S W; Chritton S L; Stoddard S L; van Heerden J A; Yaksh T L; Kelly P J
Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.
The Journal of laboratory and clinical medicine 1989;114(2):185-92.
1989: Ahlskog J E; Tyce G M; Kelly P J; van Heerden J A; Stoddard S L; Carmichael S W
Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.
Experimental neurology 1989;105(2):152-61.
1989: Stoddard S L; Ahlskog J E; Kelly P J; Tyce G M; van Heerden J A; Zinsmeister A R; Carmichael S W
Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients.
Experimental neurology 1989;104(3):218-22.
1989: Stoddard S L; Tyce G M; Ahlskog J E; Zinsmeister A R; Carmichael S W
Decreased catecholamine content in parkinsonian adrenal medullae.
Experimental neurology 1989;104(1):22-7.
1989: Ahlskog J E
Medical treatment of Parkinson's disease.
Comprehensive therapy 1989;15(3):53-9.
1989: Kelly P J; Ahlskog J E; van Heerden J A; Carmichael S W; Stoddard S L; Bell G N
Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1989;64(3):282-90.
1988: Ahlskog J E; Muenter M D
Pergolide: long-term use in Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1988;63(10):979-87.
1988: Ahlskog J E; Muenter M D
Treatment of Parkinson's disease with pergolide: a double-blind study.
Mayo Clinic proceedings. Mayo Clinic 1988;63(10):969-78.
1988: Muenter M D; Ahlskog J E; Bell G; McManis P
PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent.
Neurology 1988;38(10):1541-5.
1988: Ahlskog J E; Muenter M D; McManis P G; Bell G N; Bailey P A
Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1988;63(9):876-86.
1988: Golbe L I; Lieberman A N; Muenter M D; Ahlskog J E; Gopinathan G; Neophytides A N; Foo S H; Duvoisin R C
Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease.
Clinical neuropharmacology 1988;11(1):45-55.
1988: Carmichael S W; Wilson R J; Brimijoin W S; Melton L J; Okazaki H; Yaksh T L; Ahlskog J E; Stoddard S L; Tyce G M
Decreased catecholamines in the adrenal medulla of patients with parkinsonism.
The New England journal of medicine 1988;318(4):254.
1987: Routh L C; Black J L; Ahlskog J E
Parkinson's disease complicated by anxiety.
Mayo Clinic proceedings. Mayo Clinic 1987;62(8):733-5.
1987: Kelly P J; Ahlskog J E; Goerss S J; Daube J R; Duffy J R; Kall B A
Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1987;62(8):655-64.
1984: Ahlskog J E; Randall P K; Hernandez L; Hoebel B G
Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.
Psychopharmacology 1984;82(1-2):118-21.
1982: Ahlskog J E; O'Neill B P
Pseudotumor cerebri.
Annals of internal medicine 1982;97(2):249-56.
1977: Baez L A; Ahlskog J E; Randall P K
Body weight and regulatory deficits following unilateral nigrostriatal lesions.
Brain research 1977;132(3):467-76.
1976: Ahlskog J E
Feeding response to regulatory challenges after 6-hydroxydopamine injection into the brain noradrenergic pathways.
Physiology & behavior 1976;17(3):407-11.
1975: Ahlskog J E; Randall P K; Hoebel B G
Hupothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons.
Science (New York, N.Y.) 1975;190(4212):399-401.
1974: Ahlskog J E
Food intake and amphetamine anorexia after selective forebrain norepinephrine loss.
Brain research 1974;82(2):211-40.
1973: Ahlskog J E; Hoebel B G
Overeating and obesity from damage to a noradrenergic system in the brain.
Science (New York, N.Y.) 1973;182(108):166-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Eric Ahlskog

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Concepts & Ideas

Procedures

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Eric Ahlskog (preview)

All Publications